Accolade Inc

Company Profile

Accolade Inc had its IPO on 2020-07-02 under the ticker symbol ACCD.

The company operates in the Healthcare sector and Health Information Services industry. Accolade Inc has a staff strength of 2,350 employees.

Stock update

Shares of Accolade Inc opened at $13.14 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $12.75 - $13.31, and closed at $12.78.

This is a -3.62% slip from the previous day's closing price.

A total volume of 316,782 shares were traded at the close of the day’s session.

In the last one week, shares of Accolade Inc have slipped by -6.78%.

Accolade Inc's Key Ratios

Accolade Inc has a market cap of $925.12 million, indicating a price to book ratio of 1.3171 and a price to sales ratio of 1.7206.

In the last 12-months Accolade Inc’s revenue was $357.87 million with a gross profit of $141.00 million and an EBITDA of $-123888000. The EBITDA ratio measures Accolade Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Accolade Inc’s operating margin was -47.26% while its return on assets stood at -9.71% with a return of equity of -72.77%.

In Q3.6666666666667, Accolade Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 9%.

Accolade Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-7.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Accolade Inc’s profitability.

Accolade Inc stock is trading at a EV to sales ratio of 1.8712 and a EV to EBITDA ratio of -1.8762. Its price to sales ratio in the trailing 12-months stood at 1.7206.

Accolade Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$913.79 million

Total Liabilities

$116.62 million

Operating Cash Flow

$-1911000.00

Capital Expenditure

$3.18 million

Dividend Payout Ratio

0%

Accolade Inc ended 2024 with $913.79 million in total assets and $0 in total liabilities. Its intangible assets were valued at $913.79 million while shareholder equity stood at $485.95 million.

Accolade Inc ended 2024 with $0 in deferred long-term liabilities, $116.62 million in other current liabilities, 7000.00 in common stock, $-923861000.00 in retained earnings and $278.19 million in goodwill. Its cash balance stood at $325.64 million and cash and short-term investments were $325.64 million. The company’s total short-term debt was $7,392,000 while long-term debt stood at $281.91 million.

Accolade Inc’s total current assets stands at $366.23 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $20.48 million compared to accounts payable of $9.99 million and inventory worth $0.

In 2024, Accolade Inc's operating cash flow was $-1911000.00 while its capital expenditure stood at $3.18 million.

Comparatively, Accolade Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$12.78

52-Week High

$19.39

52-Week Low

$4.61

Analyst Target Price

$13.19

Accolade Inc stock is currently trading at $12.78 per share. It touched a 52-week high of $19.39 and a 52-week low of $19.39. Analysts tracking the stock have a 12-month average target price of $13.19.

Its 50-day moving average was $13.58 and 200-day moving average was $12.02 The short ratio stood at 4.66 indicating a short percent outstanding of 0%.

Around 242.3% of the company’s stock are held by insiders while 8195.9% are held by institutions.